Insulin Therapy in Type 2 Diabetes

Article

Zachary Bloomgarden, MD, clinical professor in the department of medicine at Mount Sinai School of Medicine, discusses the use of insulin for type 2 diabetes.

Zachary Bloomgarden, MD, clinical professor in the department of medicine at Mount Sinai School of Medicine, discusses the use of insulin for type 2 diabetes.

Click here to access this third party resource.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.